Skip to main content
Headache & Migraine Companion

Applied Companion

Headache & Migraine Companion

A structured companion for tracking headache and migraine patterns, possible triggers, medication response, daily-function effects, recovery routines, provider questions, and warning signs.

Format digital
Access $39.00
Item ID acd043

Educational support only. This resource complements, not replaces, provider instructions, facility policy, or medical advice.

Item Details

About this resource

Start here

The essentials before you go deeper.

Headache & Migraine Companion
Why This Companion Matters

Managing headache and migraine can become complicated when symptoms, instructions, appointments, and daily responsibilities are spread across different people and places. This companion is designed for people who need a clear episode history for headache, neurology, or primary-care visits. It creates one organized location for the observations, questions, and provider-directed information that are most useful between visits. The goal is not to make the reader responsible for diagnosing or treating a health problem. The goal is to make the lived experience easier to describe, the plan easier to follow, and conversations with qualified professionals more productive.

What This Companion Helps Organize

The companion brings together onset, duration, location, pain qualities, nausea, light or sound sensitivity, visual or neurologic symptoms, possible triggers, medication response, menstrual or sleep relationships, recovery time, and functional impact. Guided check-ins help the reader record what happened, when it happened, what was being done at the time, how long the change lasted, and how it affected daily function. This creates a more useful picture than isolated memories or a single symptom rating. It also gives the reader a dependable place to retain instructions, write down questions before appointments, and note the next steps established by the care team.

Daily Life and Participation

Health concerns matter because of what they change in everyday life. This companion connects observations and care-team guidance with sleep, concentration, screen use, work, school, caregiving, driving, exercise, relationships, and community activity. The reader can identify activities that have become harder, patterns that improve or worsen participation, supports that have been helpful, and priorities to discuss at the next visit. Short, structured prompts are used so the resource can remain practical even on difficult or low-energy days.

Working With the Care Team

The companion supports communication with primary-care, neurology, headache, pharmacy, behavioral-health, and rehabilitation professionals. It can be brought to appointments to clarify recent changes, confirm instructions, compare priorities, and reduce the chance that important questions will be forgotten. Any goals, precautions, action thresholds, medications, exercises, equipment recommendations, dietary directions, or progression decisions recorded in the book should come from the appropriate qualified professional. When instructions differ, the reader should pause and ask the responsible clinician to clarify the current plan.

Patterns, Check-Ins, and Preparation

Repeated check-ins make it easier to notice whether a concern is stable, improving, worsening, or changing in a new way. The reader can record dates, circumstances, functional effects, and questions without being expected to keep a lengthy daily journal. Appointment-preparation pages help translate those observations into concise information: what has changed, what matters most now, what has already been tried, and what needs professional review.

Safety Awareness

This resource includes space to retain individualized safety and escalation instructions. Prompt professional or emergency evaluation may be needed for a sudden worst headache, new weakness or speech change, loss of consciousness, fever with neck stiffness, headache after significant injury, or other emergency signs supplied by a clinician. This list is not exhaustive and does not replace the emergency directions given by a licensed professional. If symptoms are urgent, severe, rapidly worsening, or outside the expected pattern, the reader should use emergency services or contact the appropriate care team as directed.

Who May Find It Useful

This companion may be useful for the person experiencing the concern, family members or caregivers who assist with organization, and professionals who want a clearer view of changes between visits. It is intentionally flexible because individual needs, diagnoses, environments, and care plans differ. Sections can be used according to relevance while the clinical plan remains under professional direction.

Educational Scope

The Headache & Migraine Companion supports education, organization, preparation, reflection, and communication. It does not diagnose, prescribe, establish a treatment protocol, interpret emergency symptoms, or replace individualized medical, behavioral-health, rehabilitation, nutrition, pharmacy, or emergency guidance. CarePlanCompass™ publications complement—not replace—clinical care.

headache migraine companion and patterns across daily life onset duration associated symptoms possible triggers medication response recovery needs secondary warnings CarePlanCompass digital companion

Next Step Hub

Your next best move starts here.

Choose the matched bundle, continue with this resource, review connected tools, or check the evidence behind the guidance.

Best matched next step

Headache & Migraine Bundle

Built for users who want this Companion plus the most useful connected supports in one organized pathway.

Sleep & Energy Recovery Companion Hydration, Rest & Recovery Guide Headache & Migraine Tracker Headache Trigger Identification Guide
This resource

Continue with this item

Use this path when this resource is the book, guide, or support tool you came for.

Get Access

Connected Tools

Related pathway tools

8 items
Applied Companion Sleep & Energy Recovery Companion
View
Guidance Resource Hydration, Rest & Recovery Guide
View
Guidance Resource Headache & Migraine Tracker
View
Guidance Resource Headache Trigger Identification Guide
View
Guidance Resource Headache Red Flags
View
Guidance Resource Migraine Action Plan
View
View all related tools
Guidance Resource Return to Daily Activity After Migraine
View
Guidance Resource Sleep Hygiene
View

Clinical Confidence

Evidence behind this resource

20 sources
Evidence-informed

Guidance is connected to the CarePlanRx™ reference database.

AMA-style references

Sources are formatted for clinical review and transparency.

Methodology available

Users can review how references support the resource framework.

View Clinical Evidence & Methodology

View clinical references 20 sources
  1. Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. The journal of headache and pain. 2022;23(1):67. doi:10.1186/s10194-022-01431-x Source
  2. Ogrezeanu DC, Núñez-Cortés R, Salazar-Méndez J, Cuyul-Vásquez I, López-Bueno R, Ferrer-Sargues FJ et al. How much aerobic exercise is needed to reduce migraine? A dose-response meta-analysis of pain intensity and frequency. Headache. 2026;66(1):40-52. doi:10.1111/head.15070 Source
  3. Reina-Varona Á, Madroñero-Miguel B, Fierro-Marrero J, Paris-Alemany A, La Touche R. Efficacy of various exercise interventions for migraine treatment: A systematic review and network meta-analysis. Headache. 2024;64(7):873-900. doi:10.1111/head.14696 Source
  4. Onan D, Ekizoğlu E, Arıkan H, Taşdelen B, Özge A, Martelletti P. The Efficacy of Physical Therapy and Rehabilitation Approaches in Chronic Migraine: A Systematic Review and Meta-Analysis. Journal of integrative neuroscience. 2023;22(5):126. doi:10.31083/j.jin2205126 Source
  5. Haghdoost F, Puledda F, Garcia-Azorin D, Huessler EM, Messina R, Pozo-Rosich P. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia : an international journal of headache. 2023;43(4):3331024231159366. doi:10.1177/03331024231159366 Source
  6. Carcel C, Haghdoost F, Shen J, Nanda P, Bai Y, Atkins E et al. The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. Cephalalgia : an international journal of headache. 2023;43(6):3331024231183166. doi:10.1177/03331024231183166 Source
  7. Naghdi S, Underwood M, Madan J, Brown A, Duncan C, Matharu M et al. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis. The journal of headache and pain. 2023;24(1):164. doi:10.1186/s10194-023-01696-w Source
  8. Bini P, Hohenschurz-Schmidt D, Masullo V, Pitt D, Draper-Rodi J. The effectiveness of manual and exercise therapy on headache intensity and frequency among patients with cervicogenic headache: a systematic review and meta-analysis. Chiropractic & manual therapies. 2022;30(1):49. doi:10.1186/s12998-022-00459-9 Source
  9. Varangot-Reille C, Suso-Martí L, Romero-Palau M, Suárez-Pastor P, Cuenca-Martínez F. Effects of Different Therapeutic Exercise Modalities on Migraine or Tension-Type Headache: A Systematic Review and Meta-Analysis with a Replicability Analysis. The journal of pain. 2022;23(7):1099-1122. doi:10.1016/j.jpain.2021.12.003 Source
  10. Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. The journal of headache and pain. 2022;23(1):134. doi:10.1186/s10194-022-01503-y Source
  11. Lanteri-Minet M, Ducros A, Francois C, Olewinska E, Nikodem M, Dupont-Benjamin L. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data. Cephalalgia : an international journal of headache. 2022;42(14):1543-1564. doi:10.1177/03331024221123058 Source
  12. Réus JC, Polmann H, Mendes Souza BD, Flores-Mir C, Trevisol Bittencourt PC, Winocur E et al. Association Between Primary Headache and Bruxism: An Updated Systematic Review. Journal of oral & facial pain and headache. 2021;35(2):129-138. doi:10.11607/ofph.2745 Source
  13. Meydanal YE, Şenışık S, Şirin H. The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study. Headache. 2025;65(9):1593-1602. doi:10.1111/head.14951 Source
  14. Olfat M, Hosseinpour S, Masoumi S, Gogia Rastogi R, Vance Hastriter E, Lewis KS et al. A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in childhood migraine: a randomized double-blind clinical trial. Cephalalgia : an international journal of headache. 2024;44(4):3331024241230963. doi:10.1177/03331024241230963 Source
  15. Yu S, Zhou J, Luo G, Xiao Z, Ettrup A, Jansson G et al. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study. BMC neurology. 2023;23(1):441. doi:10.1186/s12883-023-03477-z Source
  16. Turkel CC, Aurora S, Diener HC, Dodick DW, Lipton RB, Silberstein SD et al. Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine. 2023;102(S1):e32600. doi:10.1097/MD.0000000000032600 Source
  17. Rani M, Kaur J. Effectiveness of spinal mobilization and postural correction exercises in the management of cervicogenic headache: A randomized controlled trial. Physiotherapy theory and practice. 2023;39(7):1391-1405. doi:10.1080/09593985.2022.2037032 Source
  18. Ellard DR, Nichols VP, Griffiths FE, Underwood M, Taylor SJC, CHESS team (Consortium). Chronic Headache Education and Self-Management Study (CHESS): a process evaluation. BMC neurology. 2023;23(1):8. doi:10.1186/s12883-022-02792-1 Source
  19. Ashina M, Lanteri-Minet M, Pozo-Rosich P, Ettrup A, Christoffersen CL, Josiassen MK et al. Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial. The Lancet. Neurology. 2022;21(7):597-607. doi:10.1016/S1474-4422(22)00185-5 Source
  20. Moreland P, Gaffney B, Lanham JS. Migraine Headache Prophylaxis. American family physician. 2025;111(5):443-450. https://pubmed.ncbi.nlm.nih.gov/40378325/ Source

CarePlanRx™

Clarity that travels with you.

CarePlanRx™ resources are designed to complement provider instructions, improve follow-through, and help people ask better questions at the right time.